Home > Insider Trading > Filing (0001209191-21-053210)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326110	Immunitybio Inc.	IBRX	Biological Products, (No Disgnostic Substances) (2836)	431979754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529371	Cheryl Cohen	C/O Immunitybio, Inc. 3530 John Hopkins Court San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-08-20	9,976	$10.00	215,418	No	4	S	Direct
Common Stock	Disposition	2021-08-23	14,801	$10.12	200,617	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021.
Represents the weighted average share price of an aggregate total of 9,976 shares sold in the price range of $10.00 to $10.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 14,801 shares sold in the price range of $10.02 to $10.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.